Skip to content

Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain

RecruitingNot applicableNCT07559890
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Determination of efficacy and safety of Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain treatment, including the method optimization.

Study details

Official title
Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain - Single-Arm Proof-of-Concept Study
Conditions
Interventions
  • Procedure: BVN ablation
Sponsor
EPC Education s.r.o.
Start date
2026-05-04
Primary completion
2027-05
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
Czechia, Slovakia, Sweden
Total sites listed
3

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Axial low back pain (with or without lateral component). * Presence of Modic type I or II changes at ≥ 1 level. * Age over 18 years. * Duration of pain ≥ 6 months. * Completion of full conservative management for ≥ 3 months. * Medial Branch Block (MBB) test performed with negative results/ or Facet Denervation done with unsatisfactory outcome (less than 50% improvement) after positive MBB test. Exclusion Criteria: * Coagulation disorders. * Platelet abnormalities. * Lack of informed consent. * Generalized solid tumor. * Hematopoietic malignancy. * Radicular pain. * Alternative primary pain generators other than axial low back pain. * Previous spinal surgery. * Targeted level located above L3/L4 * Osteoporosis

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07559890